Cellular foundation of curcumin-induced apoptosis in follicular lymphoma cell lines

Experimental Hematology

Volumn 34, Issue 4, 2006, Pages 463-474

  Skommer, Joanna ^a   Wlodkowic, Donald ^a   Pelkonen, Jukka ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CASPASE; CATHEPSIN; CURCUMIN; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; THYMIDINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DAMAGE; CELL GROWTH; CELL PERMEABILIZATION; CELL PROLIFERATION; CYTOTOXICITY; DRUG INHIBITION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FOLLICULAR LYMPHOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYSOSOME MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ASCORBIC ACID; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; ENZYME ACTIVATION; HUMANS; LYMPHOMA, FOLLICULAR; LYSOSOMES; MEMBRANE POTENTIALS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; VITAMINS;

EID: 33645210978     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.12.015     Document Type: Article

References (47)

1. A. Duvoix, R. Blasius, and S. Delhalle Chemopreventive and therapeutic effects of curcumin Cancer Lett 223 2005 181 190
2. D. Karunagaran, R. Rashmi, and T.R. Kumar Induction of apoptosis by curcumin and its implications for cancer therapy Curr Cancer Drug Targets 5 2005 117 129
3. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res 23 2003 363 398
4. S. Shishodia, H.M. Amin, R. Lai, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma Biochem Pharmacol 70 2005 700 713
5. A. Duvoix, F. Morceau, and M. Schnekenburger (2003) Curcumin-induced cell death in two leukemia cell lines: K562 and Jurkat Ann N Y Acad Sci 1010 2003 389 392
6. S. Uddin, A.R. Hussain, and P.S. Manogaran Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma Oncogene, Epub ahead of print 24 2005 7022 7030
7. M.T. Huang, H.L. Newmark, and K. Frenkel Inhibitory effects of curcumin on tumorigenesis in mice J Cell Biochem Suppl 27 1997 26 34
8. G.J. Kelloff, J.A. Crowell, and E.T. Hawk Clinical development plan: curcumin J Cell Biochem Suppl 26 1996 72 85
9. H.P. Ammon, and M.A. Wahl Pharmacology of Curcuma longa Planta Med 57 1991 1 7
10. M.L. Cleary, S.D. Smith, and J. Sklar Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation Cell 47 1986 19 28
11. D. Hockenbery, G. Nunez, C. Milliman, R.D. Schreiber, and S.J. Korsmeyer Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 22 1990 334 336
12. S.J. Horning Natural history of and therapy for the indolent non-Hodgkin's lymphomas Semin Oncol 20 1993 75 88
13. S.J. Horning, and S.A. Rosenberg The natural history of initially untreated low-grade non-Hodgkin's lymphomas N Engl J Med 311 1984 1471 1475
14. P.W. Johnson, A.Z. Rohatiner, and J.S. Whelan Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center J Clin Oncol 13 1995 140 147
15. R.J. Anto, A. Mukhopadhyay, K. Denning, and B.B. Aggarwal (2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of bcl-2 and bcl-xl Carcinogenesis 23 2002 143 150
16. M. Eray, V. Postila, and J. Eeva Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells Scand J Immunol 57 2003 545 555
17. J. Skommer, D. Wlodkowic, M. Matto, M. Eray, and J. Pelkonen HA14-1, a small molecule bcl-2 inhibitor, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells Leuk Res 30 2006 322 331
18. M. Castedo, K. Ferri, T. Roumier, D. Metivier, N. Zamzami, and G. Kroemer Quantitation of mitochondrial alterations associated with apoptosis J Immunol Methods 265 2002 39 47
19. T. Idziorek, J. Estaquier, F. De Bels, and J.C. Ameisen YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability J Immunol Methods 85 1995 249 258
20. E. Bedner, P. Smolewski, P. Amstad, and Z. Darzynkiewicz Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation Exp Cell Res 259 2000 308 313
21. P. Smolewski, J. Grabarek, H.D. Halicka, and Z. Darzynkiewicz Assay of caspase activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis J Immunol Methods 265 2002 111 121
22. M. Zhao, J.W. Eaton, and U.T. Brunk Bcl-2 phosphorylation is required for inhibition of oxidative stress-induced lysosomal leak and ensuing apoptosis FEBS Lett 509 2001 405 412
23. 2 is a consequence of lysosomal rupture Biochem J 356 2001 549 555
24. C.P. LeBel, H. Ischiropoulos, and S.C. Bondy Evaluation of the probe 2′, 7′-dichlorofluorescein as an indicator of reactive oxygen species formation and oxidative stress Chem Res Toxicol 5 1992 227 231
25. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 30 2004 626 629
26. L. Foghsgaard, D. Wissing, and D. Mauch (2001) Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor J Cell Biol 153 2001 999 1010
27. L.E. Broker, F.A. Kruyt, and G. Giaccone Cell death independent of caspases: a review Clin Cancer Res 11 2005 3155 3162
28. N. Fehrenbacher, and M. Jäättelä Lysosomes as targets for cancer therapy Cancer Res 65 2005 2993 2995
29. M. Jaattela Multiple cell death pathways as regulators of tumour initiation and progression Oncogene 23 2004 2746 2756
30. P. Pozarowski, X. Huang, D.H. Halicka, B. Lee, G. Johnson, and Z. Darzynkiewicz Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation Cytometry 55 2003 50 60
31. B. Zhivotovsky Caspases: the enzymes of death Essays Biochem 39 2003 25 40
32. J.H. Woo, Y.H. Kim, and Y.J. Choi Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of bcl-XL and IAP, the release of cytochrome c and inhibition of Akt Carcinogenesis 24 2003 1199 1208
33. S. Bhaumik, R. Anjum, N. Rangaraj, B.V. Pardhasaradhi, and A. Khar Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates FEBS Lett 456 1999 311 314
34. J. Kang, J. Chen, Y. Shi, J. Jia, and Y. Zhang Curcumin-induced histone hypoacetylation: the role of reactive oxygen species Biochem Pharmacol 69 2005 1205 1213
35. M. Yoshino, M. Haneda, and M. Naruse Prooxidant activity of curcumin: copper-dependent formation of 8-hydroxy-2′-deoxyguanosine in DNA and induction of apoptotic cell death Toxicol In Vitro 18 2004 783 789
36. M.S. Kim, H.J. Kang, and A. Moon Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells Arch Pharm Res 24 2001 349 354
37. H. Sakagami, and K. Satoh Modulating factors of radical intensity and cytotoxic activity of ascorbate Anticancer Res 17 1997 3513 3520
38. G.N. Bijur, M.E. Ariza, C.L. Hitchcock, and M.V. Williams Antimutagenic and promutagenic activity of ascorbic acid during oxidative stress Environ Mol Mutagen 30 1997 339 345
39. J.M. Grad, N.J. Bahlis, I. Reis, M.M. Oshiro, W.S. Dalton, and L.H. Boise Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells Blood 98 2001 805 813
40. M.L. Kuo, T.S. Huang, and J.K. Lin Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells Biochim Biophys Acta 1317 1996 95 100
41. D.W. Scott, and G. Loo Curcumin-induced GADD153 gene up-regulation in human colon cancer cells Carcinogenesis 25 2004 2155 2164
42. P. Ghia, V.A. Boussiotis, and J.L. Schultze Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival Blood 91 1998 244 251
43. W.L. Zhao, M.E. Daneshpouy, and N. Mounier Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma Blood 103 2004 695 697
44. M. Leist, and M. Jäättelä Four deaths and a funeral: from caspases to alternative mechanisms Nat Rev Mol Cell Biol 2 2001 589 598
45. K. Piwocka, K. Zablocki, and M.R. Wieckowski A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells Exp Cell Res 249 1999 299 307
46. G. Garcea, D.J. Jones, and R. Singh Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration Br J Cancer 90 2004 1011 1015
47. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P.S. Srinivas Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers Planta Med 64 1998 353 356